Are 16-75 years old
A Clinical Study for People with Ulcerative Colitis
If you or a loved one has ulcerative colitis, you may be eligible to participate in the ATLAS-UC clinical research study.
About the Study
What is the
ATLAS-UC Clinical Study?
Researchers are studying an investigational medication to evaluate its safety and effectiveness in individuals diagnosed with ulcerative colitis. The study aims to provide more treatment options for people with moderately to severely active UC. If eligible, you may receive study-related care at no cost.
Open to individuals aged 16-75 with ulcerative colitis.
Participants must have had UC for at least 3 months.
Study involves IV infusions and subcutaneous injections.
All study-related care and medication are provided at no cost.
Compensation may be available for study-related travel expenses.
Eligibility Criteria
Who Can Participate?
You may qualify if you:
What to Expect
What's Involved in the Study?
All medical tests and investigational study medicine will be provided at no cost.
Frequently Asked Questions
What is an investigational study medicine?
It is a medication being tested for safety and effectiveness but has not yet been approved for general use.
Will l receive a placebo?
Some participants may receive a placebo during certain study phases, but all eligible participants in the optional extension period will receive the investigational medication.
Do l have to pay for study participation?
No, all study-related care, medication, and medical tests are provided at no cost.
Will l be reimbursed for travel?
Yes, compensation may be available for study-related travel expenses.
Apply to
Join the Study
To learn more about the study, check eligibility, or participate, click on your preferred location below and complete the form on that page.
- Baton Rouge, LA
- Mansfield, TX
- Webster, TX